SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics Monthly Activity About

SEC Company Response from POMDOCTOR Ltd (POM) (CIK 0001877971) (POM) — Sep 26, 2025

POMDOCTOR Ltd (POM) (CIK 0001877971)
Date: Sept. 26, 2025 · CIK: 0001877971 · Accession: 0001213900-25-092306

AI Filing Summary & Sentiment

File numbers found in text: 333-285771

Date
September 26, 2025
Author
/s/ Damian Maggio
Form
CORRESP
Company
POMDOCTOR Ltd (POM) (CIK 0001877971)

Letter

Joseph Stone Capital, LLC

585 Stewart Avenue, Suite L-60C

Garden City, New York 11501

1 (866) 866-1433

September 26, 2025

VIA EDGAR

U.S. Securities & Exchange Commission

Division of Corporation Finance

Office of Trade & Services

100 F Street, NE

Washington, D.C. 20549

Attn:

Patrick Kuhn

Joel Parker

Scott Anderegg

Dietrich King

Re: POMDOCTOR LIMITED

Registration Statement on Form F-1

Initially filed on March 13, 2025, as amended

File No. 333-285771

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Securities Act”), Joseph Stone Capital, LLC, as representative of the several Underwriters of the offering hereby joins in the request of POMDOCTOR LIMITED to request acceleration of effectiveness of the above referenced Registration Statement on Form F-1 so that it will become effective on September 30, 2025, at 4:00 p.m. Eastern Time, or as soon thereafter as practicable.

The undersigned has complied and will comply, and has been informed or will be informed by any participating dealers that they have complied or will comply, with the requirements of Rule 15e2-8 under the Securities and Exchange Act of 1934, as amended.

Very truly yours,
By:
/s/ Damian Maggio

Show Raw Text
CORRESP
1
filename1.htm

Joseph Stone Capital, LLC

585 Stewart Avenue, Suite L-60C

Garden City, New York 11501

1 (866) 866-1433

September 26, 2025

VIA EDGAR

U.S. Securities & Exchange Commission

Division of Corporation Finance

Office of Trade & Services

100 F Street, NE

Washington, D.C. 20549

    Attn:

    Patrick Kuhn

    Joel Parker

    Scott Anderegg

    Dietrich King

    Re:
    POMDOCTOR LIMITED

    Registration Statement on Form F-1

    Initially filed on March 13, 2025, as amended

    File No. 333-285771

Ladies and Gentlemen:

Pursuant to Rule 461 under
the Securities Act of 1933, as amended (the “Securities Act”), Joseph Stone Capital, LLC, as representative of the several
Underwriters of the offering hereby joins in the request of POMDOCTOR LIMITED to request acceleration of effectiveness of the above referenced
Registration Statement on Form F-1 so that it will become effective on September 30, 2025, at 4:00 p.m. Eastern Time, or as soon thereafter
as practicable.

The undersigned has complied
and will comply, and has been informed or will be informed by any participating dealers that they have complied or will comply, with the
requirements of Rule 15e2-8 under the Securities and Exchange Act of 1934, as amended.

    Very truly yours,

    By:
    /s/ Damian Maggio

    Name:
    Damian Maggio

    Title:
    Chief Executive Officer

    cc:
    Ellenoff Grossman & Schole LLP